Press Releases

Dec 6, 2022 RESTEM Launches NK Cell Therapy Program with Publication of Results from Clinical Study of NK Cell Therapy Targeting Senescence and Age-Associated Disorders

Sep 6, 2022 RESTEM and JAR of Hope Foundation Announce Strategic Partnership and Clinical Trial Launch of Next-Generation Cell Therapy for Patients with Duchenne Muscular Dystrophy

Aug 2, 2022 UF Center for Regenerative Medicine recruiting for trial on potential therapy for autoimmune disorders

May 14, 2020 FDA approves COVID-19 trial after successful emergency use of umbilical stem cells from RESTEM